• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者的味觉障碍

Taste impairment in patients with Parkinsonism.

作者信息

Zhu Qingyong, Liu Han, Wang Jiuqi, Feng Renyi, Ma Mingming, Wang Xuejing, Ding Xuebing

机构信息

Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Department of Neurology, Henan Provincial People's Hospital, Zhengzhou, China.

出版信息

J Neurol. 2025 Mar 1;272(3):238. doi: 10.1007/s00415-025-12983-8.

DOI:10.1007/s00415-025-12983-8
PMID:40024924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11872754/
Abstract

BACKGROUND

Taste impairment is a prevalent issue among individuals with idiopathic Parkinson's disease (iPD). However, understanding taste disorders among different Parkinsonism remains incomplete. Our objective was to assess the incidence and severity of taste responses to sweet, salty, sour, bitter, and umami substances in patients with iPD, progressive supranuclear palsy (PSP), and multiple system atrophy (MSA).

METHODS

Taste function was evaluated by assessing the intensity ratings of four concentrations of sweet, salty, sour, bitter, and umami in 221 healthy controls (HCs), 251 iPD patients, 156 PSP patients, and 60 MSA patients. The Kruskal-Wallis one-way analysis was employed to discern differences in taste function among groups. Logistic regression models were utilized to analyze the association between disease severity and taste function.

RESULTS

Participants with iPD, PSP, and MSA exhibited lower total taste scores (TTS) compared to HCs (P < 0.0001, P < 0.0001, and P = 0.0002, respectively). The TTS was significantly lower in iPD patients compared to PSP and MSA patients (P = 0.0024 and P = 0.0464, respectively), with no discernible difference between PSP and MSA patients (P = 0.9998). Furthermore, in patients with iPD, both disease severity and gastrointestinal function exhibited a significant negative correlation with the TTS. However, the taste test lacked the potency to reliably distinguish iPD from PSP and MSA.

CONCLUSIONS

These research findings suggest that taste impairment emerges as a phenotype of Parkinsonism, serving as a basis for differential diagnosis and guiding dietary adjustments for patients.

摘要

背景

味觉障碍在特发性帕金森病(iPD)患者中是一个普遍存在的问题。然而,对于不同帕金森综合征患者味觉障碍的了解仍不完整。我们的目的是评估iPD、进行性核上性麻痹(PSP)和多系统萎缩(MSA)患者对甜、咸、酸、苦和鲜味物质的味觉反应的发生率和严重程度。

方法

通过评估221名健康对照者(HCs)、251名iPD患者、156名PSP患者和60名MSA患者对四种浓度的甜、咸、酸、苦和鲜味的强度评分来评估味觉功能。采用Kruskal-Wallis单向分析来辨别各组之间味觉功能的差异。使用逻辑回归模型分析疾病严重程度与味觉功能之间的关联。

结果

与HCs相比,iPD、PSP和MSA参与者的总味觉评分(TTS)较低(分别为P < 0.0001、P < 0.0001和P = 0.0002)。iPD患者的TTS显著低于PSP和MSA患者(分别为P = 0.0024和P = 0.0464),PSP和MSA患者之间无明显差异(P = 0.9998)。此外,在iPD患者中,疾病严重程度和胃肠功能均与TTS呈显著负相关。然而,味觉测试无法可靠地区分iPD与PSP和MSA。

结论

这些研究结果表明,味觉障碍是帕金森综合征的一种表型,可为患者的鉴别诊断和饮食调整提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9812/11872754/f584fdda5076/415_2025_12983_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9812/11872754/93a10650f67a/415_2025_12983_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9812/11872754/cfb8b570213f/415_2025_12983_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9812/11872754/f584fdda5076/415_2025_12983_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9812/11872754/93a10650f67a/415_2025_12983_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9812/11872754/cfb8b570213f/415_2025_12983_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9812/11872754/f584fdda5076/415_2025_12983_Fig3_HTML.jpg

相似文献

1
Taste impairment in patients with Parkinsonism.帕金森病患者的味觉障碍
J Neurol. 2025 Mar 1;272(3):238. doi: 10.1007/s00415-025-12983-8.
2
Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.进行性核上性麻痹中的神经性膀胱:与帕金森病和多系统萎缩的比较。
Neurourol Urodyn. 2018 Jun;37(5):1724-1730. doi: 10.1002/nau.23496. Epub 2018 Jan 22.
3
Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.帕金森症在18F-FDG PET上的不同代谢模式分析
Eur J Radiol. 2004 Sep;51(3):223-33. doi: 10.1016/S0720-048X(03)00214-6.
4
Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.帕金森病、进行性核上性麻痹和多系统萎缩患者自主神经功能障碍的比较。
Neurol Neurochir Pol. 2024;58(2):193-202. doi: 10.5603/pjnns.96939. Epub 2023 Dec 27.
5
Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging.利用磁化传递成像鉴别特发性帕金森病、多系统萎缩、进行性核上性麻痹与健康对照。
Neuroimage. 2004 Jan;21(1):229-35. doi: 10.1016/j.neuroimage.2003.08.028.
6
Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.进行性核上性麻痹与多系统萎缩和帕金森病认知缺陷的特征和进展。
J Neural Transm (Vienna). 2019 Nov;126(11):1437-1445. doi: 10.1007/s00702-019-02065-1. Epub 2019 Aug 20.
7
Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.全面自主神经评估无法区分帕金森病、多系统萎缩和进行性核上性麻痹。
J Neural Transm (Vienna). 2010 Jan;117(1):69-76. doi: 10.1007/s00702-009-0313-y. Epub 2009 Sep 17.
8
Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulation.使用经颅磁刺激评估多系统萎缩中的皮质脊髓束损伤
Clin Neurophysiol. 2007 Apr;118(4):815-23. doi: 10.1016/j.clinph.2007.01.004. Epub 2007 Feb 20.
9
Differentiation of parkinsonian syndromes according to differences in executive functions.根据执行功能差异对帕金森综合征进行鉴别。
J Neural Transm (Vienna). 2003 Sep;110(9):983-95. doi: 10.1007/s00702-003-0011-0.
10
[Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].[123碘标记间碘苄胍心肌闪烁显像在特发性帕金森病、多系统萎缩及进行性核上性麻痹病例中的应用]
Rinsho Shinkeigaku. 1997 Jun;37(6):476-82.

本文引用的文献

1
Detection of α-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder.通过种系扩增分析在突触核蛋白病和孤立性 REM 睡眠行为障碍中检测口腔黏膜中的 α-突触核蛋白。
Mov Disord. 2024 Aug;39(8):1300-1309. doi: 10.1002/mds.29828. Epub 2024 May 7.
2
Gustatory dysfunction is related to Parkinson's disease: A systematic review and meta-analysis.味觉障碍与帕金森病有关:系统评价和荟萃分析。
Int Forum Allergy Rhinol. 2023 Oct;13(10):1949-1957. doi: 10.1002/alr.23158. Epub 2023 Mar 30.
3
Premotor, nonmotor and motor symptoms of Parkinson's Disease: A new clinical state of the art.
帕金森病的运动前区、非运动及运动症状:最新临床进展
Ageing Res Rev. 2023 Feb;84:101834. doi: 10.1016/j.arr.2022.101834. Epub 2022 Dec 26.
4
Alpha-Synuclein species in oral mucosa as potential biomarkers for multiple system atrophy.口腔黏膜中的α-突触核蛋白作为多系统萎缩的潜在生物标志物。
Front Aging Neurosci. 2022 Oct 11;14:1010064. doi: 10.3389/fnagi.2022.1010064. eCollection 2022.
5
Multiple system atrophy.多系统萎缩
Nat Rev Dis Primers. 2022 Aug 25;8(1):56. doi: 10.1038/s41572-022-00382-6.
6
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.运动障碍学会多系统萎缩诊断标准。
Mov Disord. 2022 Jun;37(6):1131-1148. doi: 10.1002/mds.29005. Epub 2022 Apr 21.
7
Endoscopic Characteristics of Dysphagia in Multiple System Atrophy Compared to Parkinson's Disease.多系统萎缩与帕金森病吞咽困难的内镜特征比较
Mov Disord. 2022 Mar;37(3):535-544. doi: 10.1002/mds.28854. Epub 2021 Nov 13.
8
Taste, smell and mouthfeel disturbances in patients with gastrointestinal stromal tumors treated with tyrosine-kinase inhibitors.接受酪氨酸激酶抑制剂治疗的胃肠道间质瘤患者的味觉、嗅觉和口感障碍。
Support Care Cancer. 2022 Mar;30(3):2307-2315. doi: 10.1007/s00520-021-06658-z. Epub 2021 Nov 2.
9
The Non-Motor Symptom Profile of Progressive Supranuclear Palsy.进行性核上性麻痹的非运动症状概况
J Mov Disord. 2020 May;13(2):118-126. doi: 10.14802/jmd.19066. Epub 2020 Apr 6.
10
"Smelling and Tasting" Parkinson's Disease: Using Senses to Improve the Knowledge of the Disease.“嗅觉与味觉”与帕金森病:利用感官增进对该疾病的认识
Front Aging Neurosci. 2020 Feb 25;12:43. doi: 10.3389/fnagi.2020.00043. eCollection 2020.